Blood lymphocyte subsets in pigs vaccinated and challenged with Actinobacillus pleuropneumoniae.
Actinobacillus pleuropneumoniae bacterins do not induce protection in pigs while infection with low doses of the CM5 strain of A. pleuropneumoniae given by aerosol induces complete protection. To evaluate possible correlates of protection in blood lymphocyte subset phenotypes, pigs were treated with a commercial bacterin given intramuscularly, low dose (10(5)cfu/ml) aerosol infection with CM5 or control treatments of the bacterin adjuvant or phosphate buffered saline. All pigs were challenged with a high dose (10(7)cfu/ml) of A. pleuropneumoniae. Lymphocytes and sera were collected prior to and following primary and secondary immunizations and challenge, for evaluation of B- and T-cell markers and antibody to four A. pleuropneumoniae antigens. IgM(micro)+ B-cells were increased following primary exposure to antigen in the bacterin-vaccinated group only. An increase in CD4+ cells in the LD aerosol-infected group was apparent following secondary exposure to antigen. These early changes suggest little difference in lymphocyte populations between treatment groups, however, greater differences were observed following high-dose challenge; CD4+ lymphocytes were increased significantly in both bacterin and LD-challenged groups (p<0.05) while CD8+ cells decreased in the LD-group at this time period. Consequently, there were significant differences (p<0.05) in the CD4:CD8 ratio after high-dose challenge compared to earlier time points and control groups. Variation in cellular expression of SLA-DR and DQ was observed but trends correlating to treatment group were not evident. Complete protection or lack of protection associated with LD challenge or immunisation resulted in significant differences in B-cell frequencies and CD4:CD8 ratio phenotypes in pigs, but only changes in CD4:CD8 ratios appeared relevant to protection.
Appleyard
G D
GD
Department of Pathobiology, University of Guelph, Ont., Canada N1G 2W1. greg.appleyard@usask.ca
Furesz
S E
SE
Wilkie
B N
BN
D000189:Actinobacillus Infections / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D016977:Actinobacillus pleuropneumoniae / Q000276:immunology*; D000280:Administration, Inhalation; D000818:Animals; D001428:Bacterial Vaccines / Q000276:immunology; D016516:CD4-CD8 Ratio; D005434:Flow Cytometry / Q000662:veterinary; D007114:Immunization / Q000379:methods / Q000662:veterinary*; D016131:Lymphocyte Subsets / Q000276:immunology* / Q000382:microbiology; D011001:Pleuropneumonia / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control / Q000662:veterinary*; D011897:Random Allocation; D013552:Swine; D013553:Swine Diseases / Q000276:immunology* / Q000382:microbiology / Q000517:prevention & control
D001428:Bacterial Vaccines